Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Details)

v3.22.1
Shareholders' Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Oct. 09, 2017
Feb. 25, 2021
Feb. 08, 2021
Jan. 26, 2021
Sep. 27, 2020
Dec. 31, 2021
Dec. 31, 2020
Shareholders' Equity (Details) [Line Items]              
Unregistered shares of common stock       669,980      
Stock consideration (in Dollars)       $ 1,060,150      
Options for purchase     10,000        
Exercise price (in Dollars per share)     $ 1.45        
Total exercised (in Dollars)     $ 14,500     $ 469,501
Warrants for purchase   712,500          
Warrant exercise fee (in Dollars per share)   $ 2          
Total proceeds (in Dollars)           $ 1,424,998 $ 450,008
Common stock, shares outstanding           20,946,712 14,393,100
Outstanding options intrinsic value (in Dollars)           $ 1,648,200  
Option purchased (in Dollars)           1,132,000  
Weighted average fair value (in Dollars)           $ 2,700,075  
Weighted average fair value share price (in Dollars per share)           $ 2.39  
Weighted average remaining vesting period           1 year 9 months 18 days  
Unrecognized compensation expense (in Dollars)           $ 2,765,191  
Warrants to purchase shares of common stock           712,500 226,354
Keystone Equity Purchase Agreement [Member]              
Shareholders' Equity (Details) [Line Items]              
Share issued           1,645,907  
Total proceeds (in Dollars)           $ 3,850,000  
Securities Purchase Agreements [Member]              
Shareholders' Equity (Details) [Line Items]              
Share issued           2,566,669  
Total proceeds (in Dollars)           $ 7,900,007  
Equity Option [Member]              
Shareholders' Equity (Details) [Line Items]              
Common stock shares available for issuance           139,686  
Shares issued           3,359,383  
Consultant [Member]              
Shareholders' Equity (Details) [Line Items]              
Fair value of assumptions, description           This table includes warrants to purchase 144,851 shares of common stock issued to consultants, including the 53,146 shares of common stock issued during the year ended December 31, 2021, with a total fair value of $149,581 at time of issue, calculated using the Black Scholes model assuming an underlying security values of ranging between $1.30 and $2.62, volatility rate ranging between 103.8% and 110.24%, a risk-free rate ranging between 0.43% and 0.49%, and an expected term ranging from 3.00 to 5.75 years. In the year ended December 31, 2021, the Company recognized $212,927 in expense associated with these warrants, with $11,103 remaining to be recognized at December 31, 2021.   
Consultants Services [Member]              
Shareholders' Equity (Details) [Line Items]              
Share issued           713,000  
Total proceeds (in Dollars)           $ 1,980,900  
Common stock, shares outstanding           3,445,624  
Warrant [Member]              
Shareholders' Equity (Details) [Line Items]              
Total exercised (in Dollars)   $ 1,425,000          
Common Stock [Member]              
Shareholders' Equity (Details) [Line Items]              
Common stock issued, shares           713,000 446,251
Weighted average remaining vesting period           2 years 11 months 4 days  
2017 Equity Incentive Plan [Member]              
Shareholders' Equity (Details) [Line Items]              
Common stock issued, shares 1,750,000       7,500,000 694,993